# KURIA THERAPEUTICS, INC: Testing of SCO-116, an NRF2 activator for Fuchs' Dystrophy, in cultured human corneas

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | KURIA THERAPEUTICS, INC |
| Location | LITTLE ROCK, AR |
| Project | Testing of SCO-116, an NRF2 activator for Fuchs' Dystrophy, in cultured human corneas |
| Project number | 1R43EY038532-01 |
| Mechanism | R43 |
| Institute | National Eye Institute |
| Award | $306,805 |
| Awarded | 2026-09-02 |
| Project period | 2026-09-01 to 2027-08-31 |
| UEI | F7M7TD9GDA55 |

## Why this score
- Award of $306,805.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11309311). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.